Patents by Inventor Sanket PATKE

Sanket PATKE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-COMPLEMENT C1S ANTIBODY FORMULATION
    Publication number: 20240117021
    Abstract: Provided herein are compositions comprising a humanized antibody that specifically binds complement component C1s (anti-C1s antibody) that are capable of stable long-term storage. The compositions may contain, in addition to the humanized antibody, arginine or a salt thereof.
    Type: Application
    Filed: June 14, 2023
    Publication date: April 11, 2024
    Applicant: Bioverativ USA Inc.
    Inventors: Sanket Patke, Anvay Ashish Ukidve
  • ANTI-CD38 ANTIBODIES AND FORMULATIONS
    Publication number: 20230416395
    Abstract: Provided herein are antibodies that specifically bind human CD38, formulations and unit dosage forms comprising the antibodies, methods of preparing the antibodies and methods of using the antibodies.
    Type: Application
    Filed: April 14, 2023
    Publication date: December 28, 2023
    Inventors: Marielle CHIRON BLONDEL, Cendrine LEMOINE, Angela VIRONE-ODDOS, Béatrice CAMERON, Jacques DUMAS, Alain FOURNIER, Jonathan KINGSBURY, Brian MURRAY, Nathan OSTBERG, Sanket PATKE, Zichuan ZHANG
  • FGF-21 CONJUGATE FORMULATIONS
    Publication number: 20230346957
    Abstract: The present application provides pharmaceutical formulations comprising PEGylated FGF?21, e.g., a FGF-21 conjugate, and one or more stabilizers such as the chelator DPTA. The formulations can be can further stabilized by including a surfactant such as polysorbate 80 and/or adjusting the pH to about 7.1. Also provided are methods of manufacture, methods of treatment, and kits.
    Type: Application
    Filed: January 7, 2021
    Publication date: November 2, 2023
    Applicant: Bristol-Myers Squibb Company
    Inventors: Thomas PALM, Mehrnaz KHOSSRAVI, Sanket PATKE
  • Anti-CD38 antibodies and formulations
    Patent number: 11655302
    Abstract: Provided herein are antibodies that specifically bind human CD38, formulations and unit dosage forms comprising the antibodies, methods of preparing the antibodies and methods of using the antibodies.
    Type: Grant
    Filed: June 9, 2020
    Date of Patent: May 23, 2023
    Assignee: SANOFI
    Inventors: Marielle Chiron Blondel, Cendrine Lemoine, Angela Virone-Oddos, Béatrice Cameron, Jacques Dumas, Alain Fournier, Jonathan Kingsbury, Brian Murray, Nathan Ostberg, Sanket Patke, Zichuan Zhang
  • ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE
    Publication number: 20230036928
    Abstract: The present disclosure provides pharmaceutical compositions comprising anti-TGF-? antibodies and methods of use thereof.
    Type: Application
    Filed: June 17, 2022
    Publication date: February 2, 2023
    Applicant: Genzyme Corporation
    Inventors: Kiran Rana BANGARI, Ramil LATYPOV, Timothy MCCOY, Sanket PATKE
  • FGF-21 CONJUGATE FORMULATIONS
    Publication number: 20220016211
    Abstract: The present application provides pharmaceutical formulations comprising PEGylated FGF-21, e.g., a FGF-21 conjugate, and one or more stabilizers such as the chelator DPTA. The formulations can be can further stabilized by including a surfactant such as polysorbate 80 and/or adjusting the pH to about 7.1. Also provided are methods of manufacture, methods of treatment, and kits.
    Type: Application
    Filed: January 7, 2021
    Publication date: January 20, 2022
    Applicant: Bristol-Myers Squibb Company
    Inventors: Thomas PALM, Mehrnaz KHOSSRAVI, Sanket PATKE
  • FGF-21 FORMULATIONS
    Publication number: 20210260161
    Abstract: The present application provides pharmaceutical formulations comprising a FGF-21 polypeptide, e.g., a modified FGF-21 polypeptide such as PEG-FGF-21, and one or more stabilizers such as the chelator DPTA. The formulations can be can further stabilized by including a surfactant such as polysorbate 80 and/or adjusting the pH to about 7.1. Also provided are methods of manufacture, methods of treatment, and kits.
    Type: Application
    Filed: July 2, 2019
    Publication date: August 26, 2021
    Applicant: Bristol-Myers Squibb Company
    Inventors: Thomas PALM, Mehrnaz KHOSSRAVI, Sanket PATKE
  • ANTI-CD38 ANTIBODIES AND FORMULATIONS
    Publication number: 20200399391
    Abstract: Provided herein are antibodies that specifically bind human CD38, formulations and unit dosage forms comprising the antibodies, methods of preparing the antibodies and methods of using the antibodies.
    Type: Application
    Filed: June 9, 2020
    Publication date: December 24, 2020
    Inventors: Marielle CHIRON BLONDEL, Cendrine LEMOINE, Angela VIRONE-ODDOS, Béatrice CAMERON, Jacques DUMAS, Alain FOURNIER, Jonathan KINGSBURY, Brian MURRAY, Nathan OSTBERG, Sanket PATKE, Zichuan ZHANG